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Abstract
Background: The incidence of depression is expected to increase over the next 20 years, and many people will
have to deal with it. It has been reported that up to 40% of university students experience levels of depression.
Several negative consequences are associated with depression symptoms, such as memory impairment, suicide,
and substance abuse. Recently, researchers have been studying possible associations between depression and
polyunsaturated fatty acids (PUFAs), which may modify depression symptoms. The aim of the present study was to
find an association between PUFA levels and depression among Iranian postgraduate students in Malaysia.
Methods: This cross-sectional study was conducted in 2011 with 402 Iranian postgraduate students who were
studying in Malaysia. The participants included 173 (43%) women and 229 (57%) men, and the mean age of the
participants was 32.54 ± 6.22 years.
Results: After adjustment for several potential confounders including sex, age, BMI, PUFAs, MUFAs, and SFAs,
monthly expenses, close friends, living in campus, smoking, education, and marital status in a logistic regression
model, an inverse relationship was found between depression symptoms and the dietary intake of PUFAs.
Conclusion: We found an inverse association between PUFA intake and depression symptoms in Iranian postgraduate
students in Malaysia. We, therefore, concluded that long-term intake of PUFAs may modify or prevent depression
symptoms.
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Introduction
One of the most important health problems of the last
century was depression [1]. The incidence of depression
is expected to increase over the next 20 years, and many
people will have to deal with it [2]. It has been reported
that up to 40% of university students experience levels
of depression [3]. Several negative consequences are
associated with depression symptoms [4], such as mem-
ory impairment [5], suicide [6], and substance abuse [7].
Furthermore, it has been demonstrated that depression
elevates the risks of several diseases such as coronary
heart disease [8]; therefore, preventing and treating
depression are necessary to protect students from its
negative consequences.
Recently, researchers have been studying possible asso-
ciations between depression and nutrient intake, which
may modify depression symptoms. Based on the recom-
mendations of several observational, epidemiological, and
clinical studies, psychiatric disorders such as depression
m a yb em o d i f i e do ra m e n d e db yt h ei n t a k eo fe s s e n t i a l
fatty acids [9]. These studies demonstrated that increased
levels of polyunsaturated fatty acids (PUFAs) could
enhance brain function and therefore stabilize depression
symptoms [10].
Current treatments for depression cannot be targeted at
the general population because depression is a silent dis-
ease that is difficult to diagnose. Thus, other treatments
that may be applicable to the general population, such as
nutritional assessments and interventions, are needed to
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vious studies are inclusive, and more investigations are
needed. The aim of the present study was to find an asso-
ciation between PUFA levels and depression among Ira-
nian postgraduate students in Malaysia.
Materials and methods
Study design and study subjects
This cross-sectional study in 2011 was conducted on a
convenience sample of 425 Iranian postgraduate students,
who were studying in Malaysia. The participants included
173 (43%) women and 229 (57%) men, and the mean age
of the participants was 32.54 ± 6.22 years. Individuals with
serious diseases such hyperthyroidism, hypertension,
diabetes, and heart disease were excluded from the study,
as such conditions may change lifestyle factors or modify
the risk factors for depression. Students who had histories
of mental illnesses or those taking antipsychotic drugs
were excluded. Therefore, 23 students who did not meet
the eligibility criteria were excluded from the study. This
study was approved by the Scientific Counselor and Direc-
tor of Iranian Students Affairs in South East Asia in
Malaysia, and informed consent was obtained from all par-
ticipants before enrollment.
Determination of nutrient intake
A semi-quantitative food frequency questionnaire (FFQ)
that was developed by Willet et al. [11], was used to mea-
sure typical and long-term food intake. The question-
naire has been validated and used to calculate dietary
nutrient intake. Nutritionist IV software version 3.5.2 was
used to analyze the levels of saturated fatty acids, mono-
unsaturated fatty acids, and polyunsaturated fatty acids.
The saturated and unsaturated fatty acids data were
merged with sociodemographic and other variables for
statistical analysis using SPSS version 18.
Depression questionnaire
To measure depression symptoms, the self-administrated
Center for Epidemiologic Studies (CES-D) questionnaire
was employed [12]. The 20-item CES-D questionnaire
measures the current level of depressive symptoms includ-
ing appetite loss, sleep disorders, sadness, crying, feelings
of loneliness, and fear. In the CES-D questionnaire, each
question is answered using a 4-point Likert-type scale that
ranges from 0 (rarely or none of the time (less than 1
day)) to 3 (most or all the time (5-7 days)), producing a
total score of 0-60. The scoring is continuous, and a
higher score indicates greater depressive symptoms. The
cutoff score for depressive symptoms was 16.
Statistical analysis
SPSS version 18 was used for the statistical analyses via
parametric and nonparametric tests. Chi-square and
ANOVA tests were run to analyze the data. A logistic
regression analysis was performed to find an association
between PUFA levels and depression symptoms, and the
association was reported after adjustment for sex, age,
body mass index (BMI), PUFAs, monounsaturated fatty
acids (MUFAs), saturated fatty acids (SFAs), monthly
expenses, close friends, living in campus, smoking, edu-
cation, and marital status.
Results
Table 1 shows the continuous and categorical variables
of the participants based on the tertiles of PUFA intake.
SFA and MUFA levels were significantly different
among the tertiles of PUFA intake; SFA and MUFA
levels were lower in tertile 1 than in tertiles 2 and 3.
BMI values were not significantly different among the
PUFA tertiles. Monthly expenses were significantly asso-
ciated with PUFA intake; the mean monthly expenses
were higher in the second and third tertiles than in the
first tertile. Sex was not significantly different among
the tertiles of PUFA intake. Several variables, including
living in campus, years of studying, close friends, age,
and smoking (current and former), were not associated
with PUFA intake. Furthermore, there was no relation-
ship between marital status and PUFA intake, although
the first tertile featured fewer married subjects than did
the other tertiles. Lastly, the results demonstrated that a
high level of depression symptoms was associated with
low levels of dietary PUFA intake; the prevalences of
depression symptoms in the first, second, and third ter-
tiles were 29.1%, 23.9%, and 38.1%, respectively.
Further statistical analyses in this study were con-
ducted regarding the association between PUFA intake
and depression symptoms. After adjustment for all other
variables in a logistic regression model, including sex,
age, BMI, PUFAs, MUFAs, SFAs, monthly expenses,
close friends, living in campus, smoking (current and
former), education, and marital status, there was an
inverse association between depression symptoms and
the second tertile of PUFA intake (Table 2).
Discussion
To the best of our knowledge, this was the first study to
investigate an association between depression and PUFA
intake among Iranian students in Malaysia. After adjust-
ment for several potential confounders including sex,
age, BMI, PUFAs, MUFAs, and SFAs, monthly expenses,
close friends, living in campus, smoking, education, and
marital status in a logistic regression model, an inverse
relationship was found between depression symptoms
and the dietary intake of PUFAs.
Our findings extend the results of several studies that
investigated a relationship between PUFAs and depres-
sion [13-15]. A study conducted in a population above
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which is rich in PUFAs, was protective against mental
health disease [16]. Researchers in Australia also indi-
cated that a diet rich in omega-3 fatty acids improved
mood and cognitive performance [17]. A recent meta-
analysis reported that lower levels of both eicosapentae-
noic acid (EPA) and docosahexaenoic acid (DHA) were
associated with depression [18].
Although the mechanism of the association between
PUFA intake and depression is not completely clear, sev-
eral neurophysiological mechanisms may explain how
PUFAs control or modify depression symptoms. One of
the mechanisms is that neurotransmission in patients
with depression could improve with increased dietary
intake or supplementation of PUFAs. It has been demon-
strated that high PUFA intake, including DHA and EPA,
was associated with increased levels of dopamine and
dopamine D2 receptors in the frontal cortex of the rat
brain [19]. In addition, Delion et al. reported that low
intake of PUFAs increase the number of 5-hydroxytrypta-
mine (5-HT2) receptors [20]. It has been reported 5-HT2
receptors may be involved in the pathophysiology of
depression [18,21]. Researchers have emphasized a
relationship between dietary alpha-linolenic acid (ALA),
in particular, and the control of depression, as they
believe this nutrient can restart dopaminergic neuro-
transmission in the brain [22]. In addition, increased diet-
ary intake of ALA stimulates both cholinergic and
serotonergic neurotransmission [23,24].
Omega-3 fatty acid insufficiency reduces phosphatidyl-
serine (PS) levels in the rat brain cortex, brain mito-
chondria, and olfactory bulb by at least 30% [25]; PS has
antidepressant properties [26,27], and supplementation
of this nutrient can improve depression [19]. Addition-
ally, insufficient dietary intake of omega-3 fatty acids
was associated with a reduction in glucose uptake by
brain cells and cytochrome oxidase activity [28]; both
glucose uptake and cytochrome oxidase activity are indi-
cators of neuronal functional activity. Moreover, deregu-
lation of blood-brain barrier may occur due to PUFA
deficiency, which may lead to a decrease in the transport
of amino acids and glucose to the brain [29].
Another mechanism by which PUFAs may influence
depression is through inflammatory modulation [30],
which is induced via glial cells [31]. A cluster of cytokines
including interleukin-1 beta (IL-1b), IL-2, IL-6, interferon-
gamma, and tumor necrosis factor alpha (TNFa)h a v e
been reported to correlate with depression symptoms
[32-34]. These cytokines have been found to negatively
affect the central nervous systems via several pathways
such as downregulation of the hypothalamic-pituitary axis,
neurotransmitter metabolism, and neurotransmitter
mRNA levels as well as decreased neurotransmitter pre-
cursor availability [33,35,36].
It has been demonstrated that omega-3 fatty acids
may modify depression symptoms by inhibiting proin-
flammatory cytokines [37], particularly IL-1b and TNFa
Table 1 Characteristics of the subjects based on the tertile of PUFAs intake (N = 402)
Variables T1 T2 T3 P
(N = 134) (N = 134) (N = 134)
Depression Symptoms, % 38.1 23.9 29.1 0.038
Living in Campus, % 41.0 47.0 38.8 0.372
Current Smoking, % 7.5 10.4 9.0 0.693
Former Smoking, % 4.5 4.5 3.0 0.771
Married, % 44.0 56.7 54.5 0.085
Close Friends 6.00 (4.50) 7.00 (5.00) 7.86 (5.5) 0.124
PUFAs (g/day) 7.18 ± 2.12 12.67 ± 1.73 27.84 ± 10.85 0.000
SFAs (g/day) 12.03 ± 6.20 17.92 ± 7.49 32.51 ± 17.72 0.000
MUFAs (g/day) 10.86 ± 4.09 17.43 ± 6.15 34.00 ± 19.95 0.000
Age (y) 32.32 ± 6.00 32.69 ± 6.44 32.60 ± 6.17 0.879
BMI (kg/m2) 24.06 ± 3.77 24.52 ± 4.72 24.40 ± 4.23 0.669
Sex, Female/Male 45.0/54.5 36.6/63.4 47.0/53.0 0.175
Studying (y) 20.12 ± 2.11 20.45 ± 2.35 20.53 ± 2.50 0.311
Monthly Expenses ($) 761.10 ± 500.60 922.04 ± 447.94 970.67 ± 489 ± 61 0.001
T = Tertile; y = Year; SFAs = Saturated fatty acids; MUFAs = Monounsaturated fatty acids; PUFAs = Polyunsaturated fatty acids; BMI = Body mass index.
Table 2 The association between PUFAs intake and
depression
Variables OR* 95% CI p
PUFAs
Tertile 1 1.0 - -
Tertile 2 0.51 0.29-0.90 0.014
Tertile 3 0.75 0.38-1.48 0.407
*Adjusted for sex, age, BMI, PUFAs, MUFAs, SFAs, monthly expenses, close
friends, living in campus, smoking, education, and marital status.
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ulate these cytokines, omega-3 fatty acids may control
some substances involved in inflammatory processes
such as prostaglandin E2, thromboxane A2, and hista-
mine [33,35]. Furthermore, omega-3 fatty acids influence
the activities of the hypothalamic-pituitary-adrenal axis
and corticosteroid hormones [33,35].
Limitation of the study
This study was a cross-sectional study, and thus, this
design did not permit us to assess causal relationships.
For example, depression symptoms may lead to a loss of
appetite and result in reduced consumption of foods
and PUFAs, or studying in a foreign country (Malaysia)
away from family may have caused depression in our
study population. The last potential limitation is that
plasma PUFA level was not measured by the present
study and which may suggests avenues for future
studies.
Conclusion
We found an inverse association between PUFA intake
and depression symptoms in Iranian postgraduate stu-
dents in Malaysia. We, therefore, concluded that long-
term intake of PUFAs may modify or prevent depression
symptoms.
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